Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: EyeConic: Qualification for Cone-Optogenetics

View source ↗

Summary

EyeConic cone-optogenetics is in the recruitment phase for a study addressing retinal dystrophies. The sponsor is the Institute of Molecular and Clinical Ophtha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EyeConic

Snippet

Sponsor: Institute of Molecular and Clinical Ophthalmology Basel | Conditions: Retinal Dystrophies | Status: RECRUITING